Comerica Bank Astrazeneca PLC Transaction History

Comerica Bank

$25 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 22, 2023	SELL	$69.91 - $75.81 $432,393 - $468,884	-6,185 Reduced 7.89%	72,185 $117,000
Q4 2022 Jan 26, 2023	BUY	$54.21 - $70.44 $145,445 - $188,990	2,683 Added 3.54%	78,370 $0
Q3 2022 Oct 28, 2022	BUY	$53.02 - $135.75 $226,554 - $580,059	4,273 Added 5.98%	75,687 $4.18 Million
Q2 2022 Aug 02, 2022	SELL	$59.26 - $71.14 $298,848 - $358,759	-5,043 Reduced 6.6%	71,414 $4.87 Million
Q1 2022 Apr 27, 2022	BUY	$55.72 - $67.12 $13,651 - $16,444	245 Added 0.32%	76,457 $5.07 Million
Q4 2021 Feb 18, 2022	SELL	$54.02 - $63.83 $162,654 - $192,192	-3,011 Reduced 3.8%	76,212 $4.44 Million
Q3 2021 Nov 22, 2021	SELL	$55.56 - $60.79 $5.21 Million - $5.71 Million	-93,853 Reduced 54.23%	79,223 $4.76 Million
Q2 2021 Aug 26, 2021	BUY	$48.42 - $60.18 $70,160 - $87,200	1,449 Added 0.84%	173,076 $10.4 Million
Q1 2021 Apr 28, 2021	BUY	$47.16 - $54.44 $648,072 - $748,114	13,742 Added 8.7%	171,627 $8.53 Million
Q4 2020 Jan 28, 2021	SELL	$48.52 - $58.02 $151,625 - $181,312	-3,125 Reduced 1.94%	157,885 $7.89 Million
Q3 2020 Oct 30, 2020	SELL	$53.07 - $61.1 $208,512 - $240,061	-3,929 Reduced 2.38%	161,010 $8.82 Million
Q2 2020 Jul 31, 2020	BUY	$43.1 - $55.31 $186,105 - $238,828	4,318 Added 2.69%	164,939 $8.72 Million
Q1 2020 May 01, 2020	SELL	$37.79 - $51.33 $581,512 - $789,866	-15,388 Reduced 8.74%	160,621 $7.17 Million
Q4 2019 Feb 07, 2020	SELL	$42.46 - $50.46 $107,466 - $127,714	-2,531 Reduced 1.42%	176,009 $8.78 Million
Q3 2019 Oct 31, 2019	SELL	$40.12 - $45.47 $182,184 - $206,479	-4,541 Reduced 2.48%	178,540 $7.96 Million
Q2 2019 Aug 02, 2019	BUY	$37.28 - $41.68 $22,666 - $25,341	608 Added 0.33%	183,081 $0
Q1 2019 May 02, 2019	BUY	$35.49 - $43.02 $316,535 - $383,695	8,919 Added 5.14%	182,473 $0
Q4 2018 Feb 06, 2019	BUY	$36.86 - $41.49 $366,609 - $412,659	9,946 Added 6.08%	173,554 $6.17 Million
Q3 2018 Nov 01, 2018	SELL	$34.76 - $39.72 $129,480 - $147,957	-3,725 Reduced 2.23%	163,608 $6.48 Million
Q2 2018 Aug 01, 2018	SELL	$34.55 - $37.05 $487,776 - $523,071	-14,118 Reduced 7.78%	167,333 $6.22 Million
Q1 2018 May 01, 2018	SELL	$32.97 - $36.63 $189,676 - $210,732	-5,753 Reduced 3.07%	181,451 $6.42 Million
Q4 2017 Feb 02, 2018	SELL	$32.09 - $34.78 $23,297 - $25,250	-726 Reduced 0.39%	187,204 $6.71 Million
Q3 2017 Nov 06, 2017	BUY	$28.96 - $34.0 $5.44 Million - $6.39 Million	187,930	187,930 $6.35 Million

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account